9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine

C109H106N6OS — CID 164993931

IUPAC9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine
SMILESCC(C)c1ccc(N2c3ccccc3Sc3ccccc32)cc1.CC(C)c1cccc(N(c2ccccc2)c2ccccc2)c1.CC(C)c1cccc(N2c3ccccc3C(C)(C)c3ccccc32)c1.CC(C)c1cccc(N2c3ccccc3N(C)c3ccccc32)c1.CC(C)c1cccc(N2c3ccccc3Oc3ccccc32)c1
InChIInChI=1S/C24H25N.C22H22N2.C21H19NO.C21H19NS.C21H21N/c1-17(2)18-10-9-11-19(16-18)25-22-14-7-5-12-20(22)24(3,4)21-13-6-8-15-23(21)25;1-16(2)17-9-8-10-18(15-17)24-21-13-6-4-11-19(21)23(3)20-12-5-7-14-22(20)24;1-15(2)16-8-7-9-17(14-16)22-18-10-3-5-12-20(18)23-21-13-6-4-11-19(21)22;1-15(2)16-11-13-17(14-12-16)22-18-7-3-5-9-20(18)23-21-10-6-4-8-19(21)22;1-17(2)18-10-9-15-21(16-18)22(19-11-5-3-6-12-19)20-13-7-4-8-14-20/h5-17H,1-4H3;4-16H,1-3H3;2*3-15H,1-2H3;3-17H,1-2H3
InChIKeyHGVAZKZRFHJSEK-UHFFFAOYSA-N
MW1548.15 g/mol
LogP32.69
Rot. Bonds12

About 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine

9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine (PubChem CID 164993931) has the molecular formula C109H106N6OS and a molecular weight of 1548.15 g/mol. Its IUPAC name is 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine.

Molecular Properties

Compound Name9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine
PubChem CID164993931
Molecular FormulaC109H106N6OS
Molecular Weight1548.15 g/mol
Exact Mass1546.81
IUPAC Name9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine
SMILESCC(C)c1ccc(N2c3ccccc3Sc3ccccc32)cc1.CC(C)c1cccc(N(c2ccccc2)c2ccccc2)c1.CC(C)c1cccc(N2c3ccccc3C(C)(C)c3ccccc32)c1.CC(C)c1cccc(N2c3ccccc3N(C)c3ccccc32)c1.CC(C)c1cccc(N2c3ccccc3Oc3ccccc32)c1
InChIInChI=1S/C24H25N.C22H22N2.C21H19NO.C21H19NS.C21H21N/c1-17(2)18-10-9-11-19(16-18)25-22-14-7-5-12-20(22)24(3,4)21-13-6-8-15-23(21)25;1-16(2)17-9-8-10-18(15-17)24-21-13-6-4-11-19(21)23(3)20-12-5-7-14-22(20)24;1-15(2)16-8-7-9-17(14-16)22-18-10-3-5-12-20(18)23-21-13-6-4-11-19(21)22;1-15(2)16-11-13-17(14-12-16)22-18-7-3-5-9-20(18)23-21-10-6-4-8-19(21)22;1-17(2)18-10-9-15-21(16-18)22(19-11-5-3-6-12-19)20-13-7-4-8-14-20/h5-17H,1-4H3;4-16H,1-3H3;2*3-15H,1-2H3;3-17H,1-2H3
InChIKeyHGVAZKZRFHJSEK-UHFFFAOYSA-N
XLogP32.69
TPSA28.67 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds12
Heavy Atoms117
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001548.15
LogP ≤ 532.69
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N,N-bis[4-[4-(4-phenothiazin-10-ylphenyl)phenyl]phenyl]-4-phenylaniline;9,9-dimethyl-N,N-bis[4-[4-(4-phenoxazin-10-ylphenyl)phenyl]phenyl]fluoren-2-amine
CID 162159610
10-[3-(9,9-diphenylacridin-10-yl)phenyl]-9,9-diphenylacridine;10-(4-phenothiazin-10-ylphenyl)phenothiazine;10-(4-phenoxazin-10-ylphenyl)phenoxazine;1-N,1-N,3-N,3-N-tetraphenylbenzene-1,3-diamine;triphenyl-(4-triphenylsilylphenyl)silane
CID 160906604
10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]phenyl]phenoxazine;10-[4-[4-(4-phenothiazin-10-ylphenyl)-6-phenyl-1,3,5-triazin-2-yl]phenyl]phenoxazine;10-[3-phenothiazin-10-yl-5-(6-phenyl-2-pyridinyl)phenyl]phenothiazine
CID 158999619
N,N-diphenyl-4-(7,7,27,27-tetramethyl-14,20-diaza-1-boranonacyclo[17.13.1.12,6.120,28.08,13.015,33.021,26.014,35.032,34]pentatriaconta-2(35),3,5,8,10,12,15,17,19(33),21,23,25,28,30,32(34)-pentadecaen-17-yl)aniline;4-(7,27-dithia-14,20-diaza-1-boranonacyclo[17.13.1.12,6.120,28.08,13.015,33.021,26.014,35.032,34]pentatriaconta-2(35),3,5,8,10,12,15,17,19(33),21,23,25,28,30,32(34)-pentadecaen-17-yl)-N,N-diphenylaniline;10-(7,27-dithia-14,20-diaza-1-boranonacyclo[17.13.1.12,6.120,28.08,13.015,33.021,26.014,35.032,34]pentatriaconta-2(35),3,5,8,10,12,15,17,19(33),21,23,25,28,30,32(34)-pentadecaen-17-yl)phenoxazine;17-phenoxazin-10-yl-7,27-dioxa-14,20-diaza-1-boranonacyclo[17.13.1.12,6.120,28.08,13.015,33.021,26.014,35.032,34]pentatriaconta-2(35),3,5,8,10,12,15,17,19(33),21,23,25,28,30,32(34)-pentadecaene;17-(4-phenoxazin-10-ylphenyl)-7,27-dioxa-14,20-diaza-1-boranonacyclo[17.13.1.12,6.120,28.08,13.015,33.021,26.014,35.032,34]pentatriaconta-2(35),3,5,8,10,12,15,17,19(33),21,23,25,28,30,32(34)-pentadecaene;10-(7,7,27,27-tetramethyl-14,20-diaza-1-boranonacyclo[17.13.1.12,6.120,28.08,13.015,33.021,26.014,35.032,34]pentatriaconta-2(35),3,5,8,10,12,15,17,19(33),21,23,25,28,30,32(34)-pentadecaen-17-yl)phenoxazine
CID 163915008
10,10-dimethyl-5-phenyl-3-propan-2-ylbenzo[b][1,4]benzazasiline;5,10-diphenyl-2-propan-2-ylphenazine;10-methyl-3-propan-2-yl-9H-acridine;10-phenyl-2-propan-2-ylphenothiazine;10-phenyl-2-propan-2-ylphenoxazine;5-phenyl-3-propan-2-ylspiro[benzo[b][1,4]benzazasiline-10,1'-silolane];9,9,10-trimethyl-3-propan-2-ylacridine
CID 161009215
N-[4-(9,9-dimethyl-10-phenylacridin-3-yl)phenyl]-N,3-diphenylaniline
CID 121258973
N-[4-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-10-phenyl-N-(4-phenylphenyl)phenothiazin-3-amine;N-[4-(4-methoxyphenyl)phenyl]-10-phenyl-N-[4-(10-phenylspiro[acridine-9,1'-cyclopentane]-2-yl)phenyl]phenoxazin-3-amine;10-phenyl-N-[4-(10-phenylphenothiazin-3-yl)phenyl]-N-(4-phenylphenyl)phenoxazin-3-amine
CID 158449090
10-(5',5'-diphenylspiro[benzo[b][1,4]benzothiasiline-10,10'-silanthrene]-2'-yl)-9,9-dimethylacridine;10-(5',5'-diphenylspiro[benzo[b][1,4]benzothiasiline-10,10'-silanthrene]-2'-yl)phenothiazine;10-(5',5'-diphenylspiro[benzo[b][1,4]benzothiasiline-10,10'-silanthrene]-2'-yl)phenoxazine
CID 160939064
16-carbazol-9-yl-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7,9,11,14,16,18(31),20,22,24,26,28,30(32)-pentadecaene;10-(13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7,9,11,14,16,18(31),20,22,24,26,28,30(32)-pentadecaen-16-yl)phenothiazine;10-(13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7,9,11,14,16,18(31),20,22,24,26,28,30(32)-pentadecaen-16-yl)phenoxazine;16-(9,9-dimethylacridin-10-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7,9,11,14,16,18(31),20,22,24,26,28,30(32)-pentadecaene;N,N-diphenyl-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7,9,11,14,16,18(31),20,22,24,26,28,30(32)-pentadecaen-16-amine
CID 160511236
N-[4-(2,10-diphenylphenothiazin-3-yl)phenyl]-10-phenyl-N-(4-phenylphenyl)phenoxazin-3-amine
CID 90194649
10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-(4-isocyanophenyl)-1,3,5-triazin-2-yl]phenyl]phenothiazine;10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-(4-isocyanophenyl)-1,3,5-triazin-2-yl]phenyl]phenoxazine;10-[4-[4-(4-isocyanophenyl)-6-(4-phenothiazin-10-ylphenyl)-1,3,5-triazin-2-yl]phenyl]phenoxazine
CID 158328207
10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-(9,9'-spirobi[fluorene]-2-yl)-1,3,5-triazin-2-yl]phenyl]phenothiazine;10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-(9,9'-spirobi[fluorene]-2-yl)-1,3,5-triazin-2-yl]phenyl]phenoxazine;10-[4-[4-(4-phenothiazin-10-ylphenyl)-6-(9,9'-spirobi[fluorene]-2-yl)-1,3,5-triazin-2-yl]phenyl]phenoxazine
CID 158041243

Frequently Asked Questions

What is the IUPAC name of 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine?
The IUPAC name of 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine (CID 164993931) is 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine.
What is the SMILES notation for 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine?
The canonical SMILES for 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine is CC(C)c1ccc(N2c3ccccc3Sc3ccccc32)cc1.CC(C)c1cccc(N(c2ccccc2)c2ccccc2)c1.CC(C)c1cccc(N2c3ccccc3C(C)(C)c3ccccc32)c1.CC(C)c1cccc(N2c3ccccc3N(C)c3ccccc32)c1.CC(C)c1cccc(N2c3ccccc3Oc3ccccc32)c1.
What is the InChIKey of 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine?
The InChIKey is HGVAZKZRFHJSEK-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H25N.C22H22N2.C21H19NO.C21H19NS.C21H21N/c1-17(2)18-10-9-11-19(16-18)25-22-14-7-5-12-20(22)24(3,4)21-13-6-8-15-23(21)25;1-16(2)17-9-8-10-18(15-17)24-21-13-6-4-11-19(21)23(3)20-12-5-7-14-22(20)24;1-15(2)16-8-7-9-17(14-16)22-18-10-3-5-12-20(18)23-21-13-6-4-11-19(21)22;1-15(2)16-11-13-17(14-12-16)22-18-7-3-5-9-20(18)23-21-10-6-4-8-19(21)22;1-17(2)18-10-9-15-21(16-18)22(19-11-5-3-6-12-19)20-13-7-4-8-14-20/h5-17H,1-4H3;4-16H,1-3H3;2*3-15H,1-2H3;3-17H,1-2H3.
What are the key properties of 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine?
9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine has a molecular weight of 1548.15 g/mol, XLogP of 32.69, 12 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 9,9-dimethyl-10-(3-propan-2-ylphenyl)acridine;N,N-diphenyl-3-propan-2-ylaniline;5-methyl-10-(3-propan-2-ylphenyl)phenazine;10-(4-propan-2-ylphenyl)phenothiazine;10-(3-propan-2-ylphenyl)phenoxazine is sourced from PubChem (CID 164993931), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).